From: Accelerated partial breast irradiation: advances and controversies
Reported trial | Number of patients | Treatment volume | Source/dose | Median follow-up (months) | Ipsilateral recurrence rate (%) | Outcome/complications |
---|---|---|---|---|---|---|
Wazer et al. [7] | 32 | Excision cavity + 2 cm | 192Ir, 3.4 Gy BID to 34 Gy | 33 | 3 | 8 with fat necrosis, 11 with grade 3–4 skin toxicity |
Arthur et al. [8] | 44 (31 HDR, 13 LDR) | Lumpectomy cavity + 2 cm | 192Ir, HDR: 3.4 Gy BID to 24 Gy; LDR: 50 cGy/h to 45 Gy | 42 | 0 | 43% of LDR patients had radiation recall with adriamycin |
Benitez et al. [9] | 199 | Lumpectomy bed + 1–2 cm | LDR 125I, 0.52 Gy/h to 50 Gy; HDR 192Ir, 3.2-3.4 Gy BID to 32–34 Gy | 68.4 | 1.2 | 11% fat necrosis, 90% good-excellent cosmesis |
274 | Tumor bed + 2 cm | 192Ir, PDR: at 0.6 Gy pulses to 50 Gy; HDR: 4 Gy BID to 32 Gy | 63 | 2.9 | 2.6% ≥ grade 3 toxicity, 90% good to excellent cosmesis | |
Fentiman et al. [13] | 50 | Tumor bed + 2 cm | 137Cs, 4 fractions, 4–6 h/day to 45 Gy | 75.6 | 18 | 82% good to excellent cosmesis |
Polgár et al. [14] | 45 | Tumor bed + 1–2 cm | HDR 192Ir, 7 fractions of 4.33 or 5.2 Gy in 4 days to 30.3–36.4 Gy | 133 | 8.9 | 77.8% with good to excellent cosmesis, 2.2% with fat necrosis |